08:25 EDT Lantern Pharma (LTRN) trading halted, news pending
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LTRN:
- Lantern Pharma announces completion of Type C meeting with FDA
- Lantern Pharma Reports Q2 2025 Earnings and Strategic Progress
- Lantern Pharma completes targeted enrollment for HARMONIC trial
- Lantern Pharma Appoints Dr. Schalop to Board
- Lantern reports complete response in pretreated Lymphoma patient with LP-284